Matches in Nanopublications for { ?s ?p "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP630024.RAb-MMv4YH3EvlScpsnE5vka2PWZzQLCb8nKdGbvGUVUs130_assertion description "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630024.RAb-MMv4YH3EvlScpsnE5vka2PWZzQLCb8nKdGbvGUVUs130_provenance.
- assertion description "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP419757.RAd7YihP92h-Nc5HryR_BYITjeiYvW_Db_UwAnUwazQAA130_assertion description "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419757.RAd7YihP92h-Nc5HryR_BYITjeiYvW_Db_UwAnUwazQAA130_provenance.
- NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_assertion description "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_provenance.
- NP82441.RAEB6YLCWjrUSGyt7L9UYmTiQd6TDs41UWrelsPawcmvs130_assertion description "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82441.RAEB6YLCWjrUSGyt7L9UYmTiQd6TDs41UWrelsPawcmvs130_provenance.
- NP419759.RAGt7bwgF60-2ICql6WYEwpKvkXSaINyEAhlkILvMBPXY130_assertion description "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419759.RAGt7bwgF60-2ICql6WYEwpKvkXSaINyEAhlkILvMBPXY130_provenance.